This study is looking at how well the Noom digital lifestyle program works for adults who have recently started taking GLP-1 (Glucagon-Like Peptide-1 receptor agonist) medications. These medications are often used for weight loss and blood sugar control. The study wants to see if Noom can help people improve their eating habits and physical activity while they are on GLP-1s. You can join if you are 18 or older, have a BMI of 27 or higher, started a GLP-1 medication within the last 6 months, and plan to continue using it. The study will measure your diet quality using the Healthy Eating Index at the start, after 4 months, and again after 8 months. The current recruitment status is unclear, but 220 people are planned to enroll.

Study design

This interventional study will enroll 220 participants who will be randomly assigned to one of two groups. One group will receive a 4-month digital lifestyle coaching program, while the other will receive standard care and resources.

What's involved

You would participate in a 4-month digital lifestyle intervention using the Noom app, self-monitoring your diet and activity. Assessments will occur at the start, after 4 months, and again after 8 months.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 8 months, with assessments at baseline, 4 months, and 8 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.